30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Tactile Systems Technology Inc (TCMD)

Track

Over the last 90 days, Tactile Systems Technology Inc. has seen net insider selling totaling $113,403.93, primarily driven by officers. Elaine M. Birkemeyer, Chief Financial Officer, was notably involved in recent sell transactions. The company's stock has experienced a 3.6% decrease in the past 90 days, trading near the middle of its 52-week range.
Stock chart
Ticker: TCMD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Birkemeyer Elaine M.
CHIEF FINANCIAL OFFICER
2 sales — total 226,808 USD
Sale 11 May 2026
Value US$4,055,927.39 | Price 391.03 | Shares 69,408
Proposed sale 11 May 2026
Value US$4,641,710.07 | Price 224.08 | Shares 93,309
Proposed sale 25 Feb 2026
Value US$3,496,100.50 | Price 433.92 | Shares 40,106
Sale 24 Feb 2026
Value US$318,144.02 | Price 28.94 | Shares 10,993
Proposed sale 24 Feb 2026
Value US$318,148.41 | Price 28.94 | Shares 10,993
Sale 24 Feb 2026
Value US$180,764.24 | Price 28.94 | Shares 6,246
Proposed sale 24 Feb 2026
Value US$180,765.48 | Price 28.94 | Shares 6,246
Sale 24 Feb 2026
Value US$222,880.03 | Price 28.94 | Shares 7,701
Proposed sale 24 Feb 2026
Value US$222,874.64 | Price 28.94 | Shares 7,701
Sale 23 Feb 2026
Value US$5,623.08 | Price 28.69 | Shares 196
Sale 23 Feb 2026
Value US$150,520.53 | Price 28.28 | Shares 5,322
Proposed sale 23 Feb 2026
Value US$156,142.85 | Price 28.30 | Shares 5,518
Sale 23 Feb 2026
Value US$15,406.05 | Price 28.69 | Shares 537
Sale 23 Feb 2026
Value US$415,839.07 | Price 28.28 | Shares 14,703
Proposed sale 23 Feb 2026
Value US$431,246.28 | Price 28.30 | Shares 15,240
Sale 23 Feb 2026
Value US$4,590.29 | Price 28.69 | Shares 160
Sale 23 Feb 2026
Value US$121,021.67 | Price 28.28 | Shares 4,279
Proposed sale 23 Feb 2026
Value US$125,610.38 | Price 28.30 | Shares 4,439
Planned sale 2 Jan 2026
Value US$148,260.15 | Price 28.85 | Shares 5,139
Proposed sale 2 Jan 2026
Value US$148,260.15 | Price 28.85 | Shares 5,139
Sale 8 Aug 2025
Value US$95,907.27 | Price 12.36 | Shares 7,762
Proposed sale 8 Aug 2025
Value US$95,905.72 | Price 12.36 | Shares 7,762
Planned sale 12 May 2025
Value US$29,037.37 | Price 9.94 | Shares 2,921
Proposed sale 12 May 2025
Value US$29,037.38 | Price 9.94 | Shares 2,921
Sale 8 May 2025
Value US$30,954.67 | Price 9.83 | Shares 3,149
Proposed sale 8 May 2025
Value US$30,954.67 | Price 9.83 | Shares 3,149
Planned sale 8 May 2025
Value US$31,911.00 | Price 9.67 | Shares 3,300
Proposed sale 8 May 2025
Value US$31,911.00 | Price 9.67 | Shares 3,300
Proposed sale 3 Apr 2025
Value US$30,944.70 | Price 13.14 | Shares 2,355
Planned sale 25 Feb 2025
Value US$401,849.84 | Price 14.18 | Shares 28,338
Proposed sale 25 Feb 2025
Value US$401,850.84 | Price 14.18 | Shares 28,338
Sale 25 Feb 2025
Value US$93,159.90 | Price 14.40 | Shares 6,468
Proposed sale 25 Feb 2025
Value US$93,159.58 | Price 14.40 | Shares 6,468
Planned sale 25 Feb 2025
Value US$29,979.52 | Price 14.51 | Shares 2,066
Proposed sale 25 Feb 2025
Value US$29,979.54 | Price 14.51 | Shares 2,066
Proposed sale 24 Feb 2025
Value US$159,146.90 | Price 14.55 | Shares 10,938
Planned sale 24 Feb 2025
Value US$159,146.81 | Price 14.55 | Shares 10,938
Proposed sale 24 Feb 2025
Value US$70,752.98 | Price 14.65 | Shares 4,830
Sale 24 Feb 2025
Value US$70,752.74 | Price 14.65 | Shares 4,830
Proposed sale 24 Feb 2025
Value US$32,660.07 | Price 14.79 | Shares 2,209
Proposed sale 24 Feb 2025
Value US$55,538.10 | Price 14.70 | Shares 3,778
Planned sale 24 Feb 2025
Value US$55,538.11 | Price 14.70 | Shares 3,778
Sale 12 Aug 2024
Value US$20,262.53 | Price 13.07 | Shares 1,550
Proposed sale 12 Aug 2024
Value US$20,262.50 | Price 13.07 | Shares 1,550
Sale 16 May 2024
Value US$41,589.63 | Price 13.68 | Shares 3,041
Proposed sale 16 May 2024
Value US$41,589.73 | Price 13.68 | Shares 3,041
Planned sale 8 May 2024
Value US$35,150.00 | Price 14.06 | Shares 2,500
Proposed sale 8 May 2024
Value US$35,150.00 | Price 14.06 | Shares 2,500
Sale 6 May 2024
Value US$11,712.77 | Price 14.37 | Shares 815
Proposed sale 6 May 2024
Value US$11,712.74 | Price 14.37 | Shares 815
Proposed sale 29 Feb 2024
Value US$21,289.00 | Price 15.25 | Shares 1,396
Planned sale 29 Feb 2024
Value US$21,289.00 | Price 15.25 | Shares 1,396
Proposed sale 29 Feb 2024
Value US$3,705.87 | Price 15.25 | Shares 243
Planned sale 29 Feb 2024
Value US$3,705.87 | Price 15.25 | Shares 243
Planned sale 27 Feb 2024
Value US$73,148.40 | Price 15.60 | Shares 4,689
Proposed sale 27 Feb 2024
Value US$73,148.40 | Price 15.60 | Shares 4,689
Planned sale 27 Feb 2024
Value US$17,001.16 | Price 15.58 | Shares 1,091
Proposed sale 27 Feb 2024
Value US$17,001.15 | Price 15.58 | Shares 1,091
Planned sale 26 Feb 2024
Value US$32,048.58 | Price 15.91 | Shares 2,015
Proposed sale 26 Feb 2024
Value US$32,048.58 | Price 15.91 | Shares 2,015
Planned sale 26 Feb 2024
Value US$98,644.83 | Price 15.81 | Shares 6,239
Proposed sale 26 Feb 2024
Value US$98,644.98 | Price 15.81 | Shares 6,239
Planned sale 23 Feb 2024
Value US$33,278.00 | Price 14.80 | Shares 2,249
Proposed sale 23 Feb 2024
Value US$33,278.06 | Price 14.80 | Shares 2,249
Planned sale 23 Feb 2024
Value US$79,852.54 | Price 14.85 | Shares 5,378
Proposed sale 23 Feb 2024
Value US$79,852.76 | Price 14.85 | Shares 5,378
Sale 7 Aug 2023
Value US$21,807.64 | Price 20.53 | Shares 1,062
Proposed sale 7 Aug 2023
Value US$21,807.64 | Price 20.53 | Shares 1,062
Planned sale 12 May 2023
Value US$96,184.00 | Price 21.86 | Shares 4,400
Proposed sale 12 May 2023
Value US$96,184.00 | Price 21.86 | Shares 4,400
Planned sale 8 May 2023
Value US$14,658.98 | Price 18.65 | Shares 786
Proposed sale 8 May 2023
Value US$14,658.98 | Price 18.65 | Shares 786
Planned sale 8 May 2023
Value US$10,199.92 | Price 18.55 | Shares 550
Proposed sale 8 May 2023
Value US$10,199.92 | Price 18.55 | Shares 550
Sale 1 Mar 2023
Value US$19,613.10 | Price 14.10 | Shares 1,391
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-11 S Sale
2.7
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
69,408 -23.6%
391.03
US$4,055,927 		69,408 -23.6% 391.03 US$4,055,927
2026-05-11 2026-05-11 PrS Proposed sale
2.7
Birkemeyer Elaine M.

Officer

Officer
93,309
224.08
US$4,641,710 		93,309 224.08 US$4,641,710
2026-02-25 2026-02-25 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
40,106
433.92
US$3,496,100 		40,106 433.92 US$3,496,100
2026-02-26 2026-02-24 S Sale
2.4
Dodd Sheri Louise

Chief Executive Officer

Executive Director
10,993 -4.3%
28.94
US$318,144 		10,993 -4.3% 28.94 US$318,144
2026-02-26 2026-02-24 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
6,246 -7.0%
28.94
US$180,764 		6,246 -7.0% 28.94 US$180,764
2026-02-26 2026-02-24 S Sale
2.7
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
7,701 -5.4%
28.94
US$222,880 		7,701 -5.4% 28.94 US$222,880
2026-02-24 2026-02-24 PrS Proposed sale
2.4
Dodd Sheri Louise

Officer; Director

Executive Director
10,993
28.94
US$318,148 		10,993 28.94 US$318,148
2026-02-24 2026-02-24 PrS Proposed sale
2.7
Birkemeyer Elaine M.

Officer

Officer
7,701
28.94
US$222,875 		7,701 28.94 US$222,875
2026-02-24 2026-02-24 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
6,246
28.94
US$180,765 		6,246 28.94 US$180,765
2026-02-24 2026-02-23 S Sale
2.7
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
196 -0.1%
28.69
US$5,623 		196 -0.1% 28.69 US$5,623
2026-02-24 2026-02-23 S Sale
2.7
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
5,322 -3.6%
28.28
US$150,521 		5,322 -3.6% 28.28 US$150,521
2026-02-24 2026-02-23 S Sale
2.4
Dodd Sheri Louise

Chief Executive Officer

Executive Director
537 -0.2%
28.69
US$15,406 		537 -0.2% 28.69 US$15,406
2026-02-24 2026-02-23 S Sale
2.4
Dodd Sheri Louise

Chief Executive Officer

Executive Director
14,703 -5.4%
28.28
US$415,839 		14,703 -5.4% 28.28 US$415,839
2026-02-24 2026-02-23 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
160 -0.2%
28.69
US$4,590 		160 -0.2% 28.69 US$4,590
2026-02-24 2026-02-23 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
4,279 -4.6%
28.28
US$121,022 		4,279 -4.6% 28.28 US$121,022
2026-02-23 2026-02-23 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
4,439
28.30
US$125,610 		4,439 28.30 US$125,610
2026-02-23 2026-02-23 PrS Proposed sale
2.4
Dodd Sheri Louise

Officer; Director

Executive Director
15,240
28.30
US$431,246 		15,240 28.30 US$431,246
2026-02-23 2026-02-23 PrS Proposed sale
2.7
Birkemeyer Elaine M.

Officer

Officer
5,518
28.30
US$156,143 		5,518 28.30 US$156,143
2026-01-06 2026-01-02 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
5,139 -6.6%
28.85
US$148,260 		5,139 -6.6% 28.85 US$148,260
2026-01-02 2026-01-02 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
5,139
28.85
US$148,260 		5,139 28.85 US$148,260
2025-08-12 2025-08-08 S Sale
2.4
Dodd Sheri Louise

Chief Executive Officer

Executive Director
7,762 -4.3%
12.36
US$95,907 		7,762 -4.3% 12.36 US$95,907
2025-08-08 2025-08-08 PrS Proposed sale
2.4
Dodd Sheri Louise

Officer; Director

Executive Director
7,762
12.36
US$95,906 		7,762 12.36 US$95,906
2025-05-14 2025-05-12 PlS Planned sale
2.7
Birkemeyer Elaine M.

Chief Financial Officer

Officer
2,921 -2.9%
9.94
US$29,037 		2,921 -2.9% 9.94 US$29,037
2025-05-12 2025-05-12 PrS Proposed sale
2.7
Birkemeyer Elaine M.

Officer

Officer
2,921
9.94
US$29,037 		2,921 9.94 US$29,037
2025-05-12 2025-05-08 S Sale
2.4
Dodd Sheri Louise

Chief Executive Officer

Executive Director
3,149 -1.7%
9.83
US$30,955 		3,149 -1.7% 9.83 US$30,955
2025-05-09 2025-05-08 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
3,300 -6.4%
9.67
US$31,911 		3,300 -6.4% 9.67 US$31,911
2025-05-08 2025-05-08 PrS Proposed sale
2.4
Dodd Sheri Louise

Director

Non-Executive Director
3,149
9.83
US$30,955 		3,149 9.83 US$30,955
2025-05-08 2025-05-08 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
3,300
9.67
US$31,911 		3,300 9.67 US$31,911
2025-04-03 2025-04-03 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
2,355
13.14
US$30,945 		2,355 13.14 US$30,945
2025-02-27 2025-02-25 PlS Planned sale
3.6
REUVERS DANIEL L.
Non-Executive Director
28,338 -11.7%
14.18
US$401,850 		28,338 -11.7% 14.18 US$401,850
2025-02-27 2025-02-25 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
6,468 -7.7%
14.40
US$93,160 		6,468 -7.7% 14.40 US$93,160
2025-02-27 2025-02-25 PlS Planned sale
2.7
Birkemeyer Elaine M.

Chief Financial Officer

Officer
2,066 -2.0%
14.51
US$29,980 		2,066 -2.0% 14.51 US$29,980
2025-02-25 2025-02-25 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
28,338
14.18
US$401,851 		28,338 14.18 US$401,851
2025-02-25 2025-02-25 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
6,468
14.40
US$93,160 		6,468 14.40 US$93,160
2025-02-25 2025-02-25 PrS Proposed sale
2.7
Birkemeyer Elaine M.

Officer

Officer
2,066
14.51
US$29,980 		2,066 14.51 US$29,980
2025-02-24 2025-02-24 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
10,938
14.55
US$159,147 		10,938 14.55 US$159,147
2025-02-24 2025-02-24 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
4,830
14.65
US$70,753 		4,830 14.65 US$70,753
2025-02-24 2025-02-24 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
2,209
14.79
US$32,660 		2,209 14.79 US$32,660
2025-02-24 2025-02-24 PrS Proposed sale
2.7
Birkemeyer Elaine M.

Officer

Officer
3,778
14.70
US$55,538 		3,778 14.70 US$55,538
2025-02-24 2025-02-24 PlS Planned sale
3.6
REUVERS DANIEL L.
Non-Executive Director
10,938 -4.3%
14.55
US$159,147 		10,938 -4.3% 14.55 US$159,147
2025-02-24 2025-02-24 PlS Planned sale
2.7
Birkemeyer Elaine M.

Chief Financial Officer

Officer
3,778 -3.5%
14.70
US$55,538 		3,778 -3.5% 14.70 US$55,538
2025-02-24 2025-02-24 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
4,830 -5.4%
14.65
US$70,753 		4,830 -5.4% 14.65 US$70,753
2024-08-14 2024-08-12 S Sale
0.8
Ferstler Sherri Lee

Senior VP, Sales

Officer
1,550 -3.8%
13.07
US$20,263 		1,550 -3.8% 13.07 US$20,263
2024-08-12 2024-08-12 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
1,550
13.07
US$20,262 		1,550 13.07 US$20,262
2024-05-20 2024-05-16 S Sale
2.7
Birkemeyer Elaine M.

Chief Financial Officer

Officer
3,041 -4.7%
13.68
US$41,590 		3,041 -4.7% 13.68 US$41,590
2024-05-16 2024-05-16 PrS Proposed sale
2.7
Birkemeyer Elaine M.

Officer

Officer
3,041
13.68
US$41,590 		3,041 13.68 US$41,590
2024-05-10 2024-05-08 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
2,500 -9.0%
14.06
US$35,150 		2,500 -9.0% 14.06 US$35,150
2024-05-08 2024-05-08 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
2,500
14.06
US$35,150 		2,500 14.06 US$35,150
2024-05-08 2024-05-06 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
815 -1.3%
14.37
US$11,713 		815 -1.3% 14.37 US$11,713
2024-05-06 2024-05-06 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
815
14.37
US$11,713 		815 14.37 US$11,713
2024-02-29 2024-02-29 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
1,396
15.25
US$21,289 		1,396 15.25 US$21,289
2024-02-29 2024-02-29 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
243
15.25
US$3,706 		243 15.25 US$3,706
2024-02-29 2024-02-29 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
1,396 -0.6%
15.25
US$21,289 		1,396 -0.6% 15.25 US$21,289
2024-02-29 2024-02-29 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
243 -0.4%
15.25
US$3,706 		243 -0.4% 15.25 US$3,706
2024-02-29 2024-02-27 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
4,689 -1.9%
15.60
US$73,148 		4,689 -1.9% 15.60 US$73,148
2024-02-29 2024-02-27 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
1,091 -1.7%
15.58
US$17,001 		1,091 -1.7% 15.58 US$17,001
2024-02-27 2024-02-27 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
4,689
15.60
US$73,148 		4,689 15.60 US$73,148
2024-02-27 2024-02-27 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
1,091
15.58
US$17,001 		1,091 15.58 US$17,001
2024-02-27 2024-02-26 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
2,015 -3.1%
15.91
US$32,049 		2,015 -3.1% 15.91 US$32,049
2024-02-27 2024-02-26 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
6,239 -2.5%
15.81
US$98,645 		6,239 -2.5% 15.81 US$98,645
2024-02-26 2024-02-26 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
6,239
15.81
US$98,645 		6,239 15.81 US$98,645
2024-02-26 2024-02-26 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
2,015
15.91
US$32,049 		2,015 15.91 US$32,049
2024-02-27 2024-02-23 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
2,249 -4.0%
14.80
US$33,278 		2,249 -4.0% 14.80 US$33,278
2024-02-27 2024-02-23 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
5,378 -2.7%
14.85
US$79,853 		5,378 -2.7% 14.85 US$79,853
2024-02-23 2024-02-23 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
2,249
14.80
US$33,278 		2,249 14.80 US$33,278
2024-02-23 2024-02-23 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
5,378
14.85
US$79,853 		5,378 14.85 US$79,853
2023-08-09 2023-08-07 S Sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
1,062 -0.8%
20.53
US$21,808 		1,062 -0.8% 20.53 US$21,808
2023-08-07 2023-08-07 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer; Director

Executive Director
1,062
20.53
US$21,808 		1,062 20.53 US$21,808
2023-05-16 2023-05-12 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
4,400 -13.7%
21.86
US$96,184 		4,400 -13.7% 21.86 US$96,184
2023-05-12 2023-05-12 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
4,400
21.86
US$96,184 		4,400 21.86 US$96,184
2023-05-10 2023-05-08 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
786 -2.1%
18.65
US$14,659 		786 -2.1% 18.65 US$14,659
2023-05-10 2023-05-08 PlS Planned sale
2.0
PAULS ERIC

Senior VP, Sales

Officer
550 -1.8%
18.55
US$10,200 		550 -1.8% 18.55 US$10,200
2023-05-08 2023-05-08 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
786
18.65
US$14,659 		786 18.65 US$14,659
2023-05-08 2023-05-08 PrS Proposed sale
2.0
PAULS ERIC

Officer

Officer
550
18.55
US$10,200 		550 18.55 US$10,200
2023-03-03 2023-03-01 S Sale
2.1
Moen Brent

Chief Financial Officer

Officer
1,391 -2.8%
14.10
US$19,613 		1,391 -2.8% 14.10 US$19,613
Explore more

More insider trading research around Tactile Systems Technology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America